Feels like a gold rush again. Traders are leaning into space the way they leaned into EVs and crypto before — not because the fundamentals are screaming, but because the story is irresistible. Something about satellites beaming connectivity directly to your phone from low Earth orbit hits a nerve that spreadsheets can’t fully explain. The emotion in ASTS right now isn’t greed exactly. It’s more like anticipation — the specific feeling of watching a technology cross a threshold.
Sitting at $92.6 on April 3, 2026, after touching $18.2 at its 52-week low.
That range — $18.2 to $129.9 over twelve months — tells you this is not a stock for the faint-hearted. It also tells you that people who understand what AST SpaceMobile is actually building have, at different moments, been wildly right and wildly wrong about what it’s worth. The spread isn’t just volatility. It’s a disagreement about whether this company is a pre-revenue science project or the early innings of a new telecommunications infrastructure layer. The answer, based on the 2025 10-K, is starting to lean toward the latter — though barely, and with enormous asterisks still attached.
What $70.9 Million Actually Means
According to the 2025 10-K, revenue grew from $4.4 million to $70.9 million in a single year. That number deserves to sit alone for a moment before interpretation starts.
A 16x revenue jump in twelve months is the kind of figure that gets dismissed as “coming off a tiny base” — and technically that’s true, $4.4 million is almost nothing for a company with this capital structure — but the direction and velocity matter here more than the absolute level. The shift in R&D-to-revenue ratio from 651% in fiscal 2024 down to 39.6% in fiscal 2025, per the same filing, is the underlying signal worth tracking: it means the company stopped spending almost entirely on figuring out whether this can work and started spending on making it work at scale. That’s an operational gear change, not just an accounting footnote. When a deep-tech company crosses that particular threshold — from research intensity to deployment intensity — the unit economics conversation changes character entirely. The question shifts from “will it ever generate revenue” to “at what scale does this become self-sustaining,” and that’s a fundamentally more tractable problem to model.
Capex at $1.06 billion against $70.9 million in revenue per the 2025 10-K. That ratio, roughly 1,502%, is jarring.
Infrastructure businesses at the point of initial satellite constellation deployment almost always look like this. The capex represents the asset base being assembled. Every dollar of that $1.06 billion goes into hardware that, once in orbit, has near-zero marginal cost to serve an additional user. The economic model, if the constellation achieves sufficient coverage and regulatory clearance, flips from capital-destruction to capital-generation with unusual speed. The spending curve has already peaked, or is near its peak, and the revenue curve hasn’t started its real climb yet. That’s the bull thesis in its simplest form.
The Sector Noise and What to Filter
Swirling around ASTS right now: Amazon’s reported interest in Globalstar and the perennial SpaceX IPO rumor. Both drive sector sentiment, but neither is an ASTS fundamental. Amazon buying GSAT — with its $223.5 million in annual revenue per GSAT’s latest public filings, built on legacy satellite infrastructure — would validate the strategic value of owning spectrum and ground-layer connectivity assets. That’s useful framing for ASTS investors. It is not a substitute for ASTS executing its own deployment roadmap.
SpaceX going public changes liquidity dynamics for the entire sector. Full stop.
Comparing ASTS directly to Globalstar is instructive precisely because they solve different problems. GSAT’s revenue base anchors itself in a service model requiring dedicated hardware on the user’s end or specific device integrations. AST’s approach — direct-to-standard-smartphone connectivity, no special hardware required — scales more aggressively if it works, and presents structurally more complex execution and regulatory risk if it doesn’t. GSAT operates as a mature, narrow-moat business. ASTS presents a binary outcome dressed in a satellite constellation. Investors should not treat them as comparable risk profiles just because they share a sector.
Regulatory approval timelines are the variable nobody has cleanly priced. Spectrum licensing across major commercial markets — the U.S., Europe, India, Southeast Asia — operates on bureaucratic schedules that have no sympathy for a company’s burn rate or investor impatience. Each jurisdiction evaluates interference risk between low-earth-orbit satellite signals and existing terrestrial cellular networks under its own framework. Some of those reviews sit months from resolution. Some sit years away. The commercial rollout of space-to-cellular connectivity at scale cannot happen faster than the slowest regulator in a given target market, and that’s a ceiling on near-term revenue that doesn’t show up cleanly in any financial model.
The weakest assumption in the bull case: that regulatory clearance across multiple major markets will proceed on a timeline compatible with the company’s current cash runway. Here’s where it could genuinely break — if spectrum approval in one or two major markets gets delayed past 2027, the cash consumption math becomes difficult to sustain without additional dilutive capital raises. If a Starlink-adjacent offering from SpaceX, post-IPO and armed with a freshly liquid balance sheet, accelerates competitive positioning in the direct-to-device space, ASTS loses first-mover narrative faster than expected. If the Amazon-Globalstar deal triggers a regulatory reassessment of spectrum consolidation that slows new entrants, the path to commercialization gets longer and more expensive simultaneously. None of these scenarios are base case. All of them are possible.
What the current price at $92.6 reflects, most honestly, is a market that has decided to bet on the deployment phase accelerating faster than the risks can accumulate. That’s not irrational. It’s a legitimate read of where the company stood twelve months ago versus where it stands now. The revenue trajectory, the R&D ratio compression, the capex profile — these all point toward a company past the theoretical stage and deep into execution. The compounding power of the completed constellation is not yet priced in. The question is whether the runway is long enough to get there without structural dilution that erodes per-share value even as the enterprise grows.
I keep returning to that 16x revenue number. I’m not sure it’s being read carefully enough.
The transition from $4.4M to $70.9M isn’t just growth — it’s evidence of first commercial contracts closing, which means at least some regulatory clearances have already been granted in at least some markets. The machine is running. It’s running slowly relative to the capital it’s consuming. Whether “slowly” becomes “sustainably” within the next 18 months is the only question that matters, and the answer isn’t in any filing available today.
People love to talk about disruption until the bill arrives, and then they’re shocked — shocked — that satellites cost a billion dollars and regulators don’t care about your burn rate.